Headquartered in Brookwood, AL Fiscal year ends December NYSE: HCC warriormetcoal.com
Warrior Met Coal, Inc. (NYSE: HCC) is a U.S.-based producer and exporter dedicated entirely to non-thermal metallurgical (steelmaking) coal, also known as hard-coking coal (HCC). Its customers are steel manufacturers in Europe, South America and Asia.
The company runs longwall operations at underground mines in Alabama, including Mine No. 7 and the newly built Blue Creek mine. Blue Creek began longwall production about a year ago, finished construction in early 2026, and is now driving large volume growth. Warrior's HCC from the Blue Creek coal seam has very low sulfur and strong coking properties, making it suited as a base feed coal for steelmakers.
The company sells Premium Low-Vol and High-Vol A coals, priced against indices such as the Platts PLV FOB Australian index. It ships through the McDuffie Terminal at the Port of Mobile, with growing sales into the Pacific Basin. Its revenue depends on global steel demand, met coal index prices and seaborne freight rates. It returns capital through regular quarterly and special dividends. Updated
Blue Creek is already paying shareholders a $2.00 special dividend, roughly $106 million, on top of the regular $0.08 payout. Earnings still came in well short of the $1.45 consensus as Pacific freight costs and a heavier High-Vol A mix cut price realization to about 66% from 83%.
Warren Buffett's step back from Berkshire forces a harder question: which public companies actually run his playbook, and how close do any of them get to the real thing?
Long bonds are doing something they have not done in years: pricing real risk. With the 10-year Treasury at 4.67% and the 20- and 30-year already above 5%, capital is rotating out…
Warrior Met Coal, Inc. (NYSE: HCC) is a U.S.-based producer and exporter dedicated entirely to non-thermal metallurgical (steelmaking) coal, also known as hard-coking coal (HCC). Its customers are steel manufacturers in Europe, South America and Asia.
24/7 Wall St.'s 12-month price target for HCC is $93.16, rated Buy. The Wall Street consensus target is $106.50. HCC price prediction →
